Mitochondrial Transplantation/Transfer: Promising Therapeutic Strategies for Spinal Cord Injury

Area of Science:

• Neuroscience
• Regenerative Medicine
• Mitochondrial Biology

Background:

• Spinal cord injury (SCI) is a complex condition with limited effective treatments.
• Mitochondrial dysfunction, characterized by calcium overload and reactive oxygen species (ROS), is a key factor in SCI-induced neuronal damage.

Purpose of the Study:

• To review current research on mitochondrial transplantation and transfer for SCI treatment.
• To analyze therapeutic implications, influencing factors, and delivery methods for mitochondrial therapies in SCI.
• To identify future research directions for advancing SCI regenerative therapies.

Main Methods:

• Review of existing literature on mitochondrial transplantation and transfer in SCI.
• Analysis of endogenous mitochondrial transfer and exogenous mitochondrial transplantation approaches.
• Exploration of advanced delivery methods and influencing factors.

Main Results:

• Mitochondrial transplantation shows potential for restoring neuronal bioenergetic function in SCI.
• Challenges include optimizing delivery, dosage, scalability, sourcing, regulatory issues, and integration.
• Successful integration requires validation in large animal models and clinical trials.

Conclusions:

• Mitochondrial transplantation is a promising therapeutic strategy for SCI.
• Addressing key challenges is crucial for translational success.
• This approach can bridge mitochondrial biology and translational engineering for SCI regenerative therapies.